FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
Healio50m
FDA approves Spravato as monotherapy for adults with major depressive disorder
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
Hosted on MSN19m
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
Managed Healthcare Executive11h
FDA Approves Spravato Nasal Spray as a Standalone Treatment for Major Depressive Disorder
One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
WAMC18h
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
btimesonline21h
FDA Approves Johnson & Johnson's Spravato as Standalone Treatment for Depression
The Food and Drug Administration has approved Johnson & Johnson's nasal spray Spravato (esketamine) as a standalone treatment ...
STAT9d
Pharmalittle: We’re reading about J&J and GSK deals, a departing FDA official, and more
The move by J&J, which also sells Spravato for treatment-resistant depression, reflects how the pharmaceutical industry has come back to neuropsychiatric drug development after largely leaving the ...
KXAN8d
Innovative, Life Changing TMS Therapy for Depression at New Directions Mental Health
NeuroStar TMS is FDA-cleared for the treatment of Major Depressive ... medication management, Spravato treatment, and psychological testing and evaluation, visit https://newdirectionspgh.com ...
Psychology Today4d
Psychiatrists in Mercer County, NJ
View cities in Mercer County Female Male ...
Yahoo Finance23d
Relief Mental Health Honored with BEST of 2024 Award in Red Bank, NJ
SPRAVATO® (Esketamine): SPRAVATO® is an innovative treatment for treatment-resistant depression or depression with suicidal thoughts or actions. Administered under medical supervision, this ...